Please assess the completion status of the following clinical trial:

Trial Title: Minimally Invasive Tongue Suture For Obstructive Sleep Apnea

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~Five patients will be recruited during a period of one year, or until a total of five patients have been recruited and have taken part. Patients must have undergone a formal overnight polysomnogram with documented obstructive sleep apnea within the past 2 years with no significant change in their weight or symptoms. They must have tried or refused all available nonsurgical options (CPAP or mandibular advancement devices), and must be ideal candidates for traditional upper airway surgery. Based on the polysomnogram results and specific entry criteria, patients will be recruited. All patients will undergo a full ENT examination and a fiberoptic laryngoscopy, examining the nasal cavity, palatal structures and tongue position, both in the sitting and supine positions (a routine part of the ENT examination).~Entry criteria include the following:~* men and women ages 18 to 65~* supine Park tongue position 3+ or greater~* tonsil size 2 or less~* Mueller's 2+ or less~* Friedman Stage II/III~* BMI ≤ 30~* AHI ≥ 5~Exclusion Criteria:~* Prior pharyngeal surgery~* History of radiation to the head and neck~* Dysmorphic facies or craniofacial syndrome~* ASA class IV or V~* Major depression or unstable psychiatric disorder~* Pregnancy~* Illiteracy (unable to complete required forms)~* No phone # or mailing address, or plans to change in 3 month period~* Any upper airway surgery within three month period

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): Pilot study of 5 patients, with an additional 20 patients with conditional approval by the IRB once the initial 5 patient's data is reviewed.

Based on this trial design, predict the completion outcome and termination type (if applicable).